Detalhe da pesquisa
1.
In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms.
Blood
; 2024 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38457657
2.
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms.
Am J Hematol
; 98(7): 1029-1042, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37203407
3.
Identification and characterization of hydrophobic gate residues in TRP channels.
FASEB J
; 32(2): 639-653, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28970257
4.
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.
Support Care Cancer
; 26(7): 2217-2227, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29392478
5.
Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib.
Br J Haematol
; 197(4): e49-e52, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35128632
6.
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis.
Ther Adv Hematol
; 15: 20406207241237607, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38481947
7.
Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.
Exp Hematol
; 132: 104178, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38340948
8.
Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms.
J Clin Invest
; 134(3)2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38060311
9.
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
Cancer Res
; 84(8): 1333-1351, 2024 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38277141
10.
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice.
Exp Hematol
; 128: 48-66, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37611729
11.
DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression.
Nat Cancer
; 4(1): 108-127, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36581736
12.
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis.
Blood Adv
; 7(19): 5835-5842, 2023 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37552106
13.
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition.
Blood Adv
; 6(2): 611-623, 2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34644371
14.
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers.
Cancer Res
; 80(3): 444-457, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31722999
15.
eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer.
Mol Cancer Ther
; 18(11): 2158-2170, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31395685
16.
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Nat Commun
; 10(1): 557, 2019 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30718506
17.
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Nat Commun
; 10(1): 558, 2019 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30718512
18.
Direct Binding between Pre-S1 and TRP-like Domains in TRPP Channels Mediates Gating and Functional Regulation by PIP2.
Cell Rep
; 22(6): 1560-1573, 2018 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29425510
19.
Ethnic Differences in Genetic Ion Channelopathies Associated with Sudden Cardiac Death: A Systematic Review and Meta-Analysis.
Ann Clin Lab Sci
; 47(4): 481-490, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28801377